Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlycoMimetics Inc (NASDAQ:GLYC)

8.47
Delayed Data
As of May 27
 +0.23 / +2.79%
Today’s Change
3.70
Today|||52-Week Range
9.22
+48.08%
Year-to-Date

Today’s Trading

Previous close8.24
Today’s open8.25
Day’s range8.05 - 8.80
Volume223,581
Average volume (3 months)31,833
Market cap$163.9M
Dividend yield--
Data as of 3:59pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-11.67%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+33.56%
P/E ratioNM
Price/Sales5.42
Price/Book3.99

Competitors

 Today’s
change
Today’s
% change
DRRXDURECT Corp-0.01-0.83%
TTPHTetraphase Pharmaceu...+0.17+3.98%
LPCNLipocine Inc+0.03+0.33%
ECYTEndocyte Inc+0.07+1.86%
Data as of 3:59pm ET, 05/27/2016

Financials

Next reporting dateJuly 29, 2016
EPS forecast (this quarter)-$0.45
Annual revenue (last year)$20.1M
Annual profit (last year)-$12.8M
Net profit margin-63.62%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Rachel K. King
Chief Financial Officer
Brian M. Hahn
Corporate headquarters
Rockville, Maryland

Forecasts

Partner Offers

Search for Jobs